Intelligence / Healthtech / New Clinical Trials / Iongen Therapeutics Co., Ltd.
Clinicaltrial registered9 Nov 2026
Iongen Therapeutics Co., Ltd.
9 Nov 2026: Trial registered · A Study to Assess IG001643 in Healthy Participants. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 9 Nov 2026
- Title
- A Study to Assess IG001643 in Healthy Participants
- Conditions
- Pain Management
- Phase
- Phase 1
- Study Type
- Interventional
- Status
- Not Yet Recruiting
- Countries
- New Zealand
- Country
- New Zealand
- Reference
- NCT07924397
- Location
- New Zealand
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Iongen Therapeutics Co., Ltd.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
More from New Zealand
New Clinical Trials
17 NovNS Pharma, Inc.trial registered · A Global Phase 2 Extension Study of Brogidirsen in Boys With Duchenne Muscular DystrophyClinical4 NovAntlia Bioscience, Inctrial registered · Study of AB-110 in Healthy and Hypertensive ParticipantsClinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.